Butabarbital will reduce the extent or impact of fedratinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Influence of coadministering a powerful CYP3A4 inducer with fedratinib has not been analyzed. Butabarbital, most often generally known as Butisol commercially, is undoubtedly an accepted Routine III drug in the https://lemmyj110mqr7.prublogger.com/profile